Open AccessDistribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications
Author(s) -
Nastaran Neishaboori,
Roopma Wadhwa,
Graciela M. NoguerasGonzález,
Elena Elimova,
Hironori Shiozaki,
Kazuki Sudo,
Nikolaos Charalampakis,
Adarsh Hiremath,
Jeffrey H. Lee,
Manoop S. Bhutani,
Brian Weston,
Mariela A. Blum,
Jane E. Rogers,
Jeana L. Garris,
David C. Rice,
Ritsuko Komaki,
Stephen G. Swisher,
Heath D. Skinner,
Wayne L. Hofstetter,
Jaffer A. Ajani
Publication year - 2015
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000371889
Subject(s) - submucosa , medicine , adenocarcinoma , esophagus , gastroenterology , stage (stratigraphy) , pathology , carcinoma , esophageal cancer , cancer , biology , paleontology
We have limited knowledge of the geographic distribution of resistant esophageal adenocarcinoma (EAC) in resected specimens, but its clinical importance can be enormous.